Pubblicazioni

Duration of response to first androgen deprivation therapy, time to castration resistance prostate cancer, and outcome of metastatic castration resistance prostate cancer patients treated with abiraterone acetate

2017 - ANTI-CANCER DRUGS

Giacinti, Silvana; Carlini, Paolo; Roberto, Michela; Bassanelli, Maria; Strigari, Lidia; Pavese, Francesco; Aschelter, Anna M.; Felici, Alessandra; Valeriani, Maurizio; Cognetti, Francesco; Marchetti, Paolo

New perspectives in glioblastoma: Nanoparticles-based approaches

2017 - CURRENT CANCER DRUG TARGETS

Luciano, Rosa; Battafarano, Giulia; Saracino, Rossana; Rossi, Michela; Perrotta, Antonio; Manco, Melania; Muraca, Maurizio; Del Fattore, Andrea

The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer

2016 - ANTI-CANCER DRUGS

Romiti, Adriana; Roberto, Michela; D'Antonio, Chiara; Onesti, CONCETTA ELISA; Barucca, Viola; Milano, Annalisa; Gentile, Giovanna; Lionetto, Luana; Medda, Emanuela; Mazzuca, Federica; Botticelli, Andrea; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo

A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer

2015 - ANTI-CANCER DRUGS

Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo

A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: A multicentric Italian experience

2015 - ANTI-CANCER DRUGS

Martella, Francesca; Salutari, Vanda; Marchetti, Claudia; Pisano, Carmela; Di Napoli, Marilena; Pietta, Francesca; Centineo, Dina; Caringella, Anna M.; Musella, Angela; Fioretto, Luisa